Gastroenterology - European Medical Journal

Continue

Gastroenterology

Articles
12 Mins
1st December 2016

Relevance of Patient-Reported Outcomes for the Management of Patients with Inflammatory Bowel Disease

Patient adherence is a major problem in the treatment of inflammatory bowel disease (IBD). Research has shown that improved patient adherence and…
14 Mins
1st December 2016

Crohn’s Disease: Supporting Patients in Their Pursuit of Disease Control

The objectives of this symposium were to describe the current unmet needs in the treatment and management of inflammatory bowel diseases (IBDs) in…
14 Mins
1st December 2016

Editor’s Pick: “Should I Be Concerned with the Long-Term Use of Proton Pump Inhibitor Therapy?”

Proton pump inhibitors (PPI) are one of the most widely prescribed drugs worldwide. They are the mainstay for treatment of most gastric acid-related…
18 Mins
1st December 2016

Assessing Alterations in Food Preference as a Mechanism Contributing to Weight Loss After Gastric Bypass Surgery

Roux-en-Y gastric bypass (RYGB) surgery is a very successful option for the management of obesity, and our understanding of how this intervention…
16 Mins
1st December 2016

Eosinophilic Oesophagitis: From Rare to Commonplace, What Are the Potential Explanations?

In this century, eosinophilic oesophagitis (EoE) has become a more recognised allergic disease, resulting in the publication of two consensus reports…
17 Mins
1st December 2016

Eosinophilic Oesophagitis: Current Understanding and Future Directions

Eosinophilic oesophagitis (EoE) is an emerging disorder that manifests clinically with characteristic symptoms of oesophageal dysfunction…
15 Mins
1st December 2016

Infliximab and Tumour Necrosis Factor Alpha Measurement on Intestinal Mucosa: A New Tool for the Clinic?

Background: Infliximab (IFX) trough levels measurement could partially explain mechanisms of loss in response to this drug.
18 Mins
1st December 2016

Barrett’s Oesophagus in 2016

Barrett’s oesophagus (BO) is one of the most important complications of gastro-oesophageal reflux disease as it may progress to oesophageal adenocarcinoma.